Lonza Group AG | Ownership
Companies that own Lonza Group AG
BlackRock Investment Management (UK) Ltd.
2,287,857
3.07%
-41,481
0.2%
07/31/2018
OppenheimerFunds, Inc.
2,071,494
2.78%
-953,620
0.39%
01/25/2018
The Vanguard Group, Inc.
1,905,493
2.56%
15,322
0.02%
07/31/2018
Fidelity Management & Research Co.
1,749,225
2.35%
17,535
0.06%
07/31/2018
Norges Bank Investment Management
1,736,159
2.33%
-506,028
0.08%
02/17/2018
UBS AG (Investment Management)
1,547,822
2.08%
22,436
0.38%
09/04/2018
TIAA-CREF Investment Management LLC
1,433,945
1.93%
284,527
0.23%
07/31/2018
Schroder Investment Management Ltd.
1,184,709
1.59%
39,732
0.25%
06/30/2018
BlackRock Fund Advisors
1,019,532
1.37%
7,353
0.02%
09/06/2018
Artisan Partners LP
986,212
1.32%
217,991
0.34%
06/30/2018
| Address |
Muenchensteinerstrasse 38
Basel Basel-Stadt (Basle Town) 4002
Switzerland
|
|
Employees
|
- |
| Website |
http://www.lonza.com |
| Updated |
09/14/2018 |
| Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the Pharma&Biotech and Specialty Ingredients segemnts. The Pharma&Biotech segment deals with the supply of pharmaceutical ingredients and biopharmaceuticals as well as research and testing products and services. |
